State Of Alaska, Department Of Revenue Regenxbio Inc. Transaction History

State Of Alaska, Department Of Revenue

$8.78 Billion
Q1 2024

A detailed history of State Of Alaska, Department Of Revenue transactions in Regenxbio Inc. stock. As of the latest transaction made, State Of Alaska, Department Of Revenue holds 24,656 shares of RGNX stock, worth $268,750. This represents 0.01% of its overall portfolio holdings.

Number of Shares

24,656

Previous 24,899 0.98%

Holding current value

$268,750

Previous $446,000 16.37%

% of portfolio

0.01%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 19, 2024	SELL	$12.17 - $24.61 $2,957 - $5,980	-243 Reduced 0.98%	24,656 $519,000
Q4 2023 Jan 19, 2024	SELL	$12.89 - $20.82 $3,622 - $5,850	-281 Reduced 1.12%	24,899 $446,000
Q3 2023 Oct 16, 2023	BUY	$16.46 - $19.99 $4,905 - $5,957	298 Added 1.2%	25,180 $414,000
Q2 2023 Jul 24, 2023	SELL	$17.23 - $21.71 $15,696 - $19,777	-911 Reduced 3.53%	24,882 $497,000
Q1 2023 Apr 17, 2023	SELL	$18.08 - $24.55 $7,846 - $10,654	-434 Reduced 1.65%	25,793 $487,000

Q4 2022 Jan 11, 2023	BUY	$20.4 - $24.73 $3,835 - $4,649	188 Added 0.72%	26,227 $594,000
Q3 2022 Oct 20, 2022	SELL	$22.29 - $35.04 $57,017 - $89,632	-2,558 Reduced 8.94%	26,039 $688,000
Q2 2022 Jul 08, 2022	BUY	$19.35 - $35.04 $46,827 - $84,796	2,420 Added 9.24%	28,597 $706,000
Q1 2022 Apr 14, 2022	SELL	$24.62 - $34.31 $11,694 - $16,297	-475 Reduced 1.78%	26,177 $868,000
Q4 2021 Jan 12, 2022	SELL	$30.19 - $40.28 $20,982 - $27,994	-695 Reduced 2.54%	26,652 $871,000
Q3 2021 Oct 07, 2021	BUY	$29.09 - $45.68 $93,844 - $147,363	3,226 Added 13.37%	27,347 $1.15 Million
Q2 2021 Jul 12, 2021	BUY	$32.46 - $40.48 $17,041 - $21,252	525 Added 2.22%	24,121 $937,000
Q1 2021 Apr 09, 2021	BUY	$33.61 - $49.95 $10,419 - $15,484	310 Added 1.33%	23,596 $804,000
Q4 2020 Jan 08, 2021	SELL	$26.52 - $49.35 $120,082 - $223,456	-4,528 Reduced 16.28%	23,286 $1.06 Million
Q3 2020 Oct 05, 2020	SELL	$27.01 - $40.26 $55,100 - $82,130	-2,040 Reduced 6.83%	27,814 $765,000
Q2 2020 Jul 06, 2020	BUY	$27.75 - $43.44 $24,420 - $38,227	880 Added 3.04%	29,854 $1.1 Million
Q1 2020 Apr 06, 2020	BUY	$21.5 - $54.2 $114,165 - $287,802	5,310 Added 22.44%	28,974 $938,000
Q4 2019 Jan 07, 2020	SELL	$34.54 - $44.87 $12,917 - $16,781	-374 Reduced 1.56%	23,664 $969,000
Q3 2019 Oct 02, 2019	BUY	$31.84 - $50.88 $431,877 - $690,136	13,564 Added 129.5%	24,038 $855,000
Q2 2019 Jul 23, 2019	BUY	$42.0 - $59.29 $6,888 - $9,723	164 Added 1.59%	10,474 $538,000
Q1 2019 Apr 09, 2019	BUY	$40.82 - $62.45 $10,000 - $15,300	245 Added 2.43%	10,310 $590,000
Q4 2018 Jan 10, 2019	BUY	$39.11 - $75.15 $18,577 - $35,696	475 Added 4.95%	10,065 $422,000
Q3 2018 Oct 09, 2018	BUY	$65.0 - $82.15 $53,300 - $67,363	820 Added 9.35%	9,590 $724,000
Q2 2018 Jul 10, 2018	BUY	$27.2 - $74.35 $238,544 - $652,049	8,770 New	8,770 $629,000

Others Institutions Holding RGNX

# of Institutions

193

Shares Held

42.1M

Call Options Held

80.6K

Put Options Held

55.2K

View Full List

About REGENXBIO Inc.

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $471M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

More about RGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Alaska, Department Of Revenue, based on Form 13F filings with the SEC.

News

Stay updated on State Of Alaska, Department Of Revenue with notifications on news.

Account

State Of Alaska, Department Of Revenue Regenxbio Inc. Transaction History